Home » Tenders » Americas » USA » Antidote Treatment Nerve Agent Auto-Injector (Atnaa) Tender, USA - 99090676

Antidote Treatment Nerve Agent Auto-Injector (Atnaa) Tender, USA - 99090676

DEPT OF DEFENSE has floated a tender for Antidote Treatment Nerve Agent Auto-Injector (Atnaa). The project location is USA and the tender is closing on 04 Apr 2024. The tender notice number is SPE2DP-23-R-0002, while the TOT Ref Number is 99090676. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : USA

Summary : Antidote Treatment Nerve Agent Auto-Injector (Atnaa)

Deadline : 04 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 99090676

Document Ref. No. : SPE2DP-23-R-0002

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : DEPT OF DEFENSE
Contracting Office Address : PHILADELPHIA, PA 19111
Primary Point of Contact : Jessica De La Hoz
jessica.delahoz@dla.mil
Phone Number 215-737-7137

USA
Email :jessica.delahoz@dla.mil

Tender Details

Description

Solicitation: SPE2DP-23-R-0002

Item: ANTIDOTE TREATMENT, NERVE AGENT, Automatic, Dual-Chamber, Pralidoxime Chloride Injection, 300 mg per mL, 2 mL, and Atropine Injection, 2.99 mg per mL, 0.7 mL

NSN: 6505-01-362-7427

Description:

The Defense Logistics Agency Troop Support has a requirement for the supply of Antidote Treatment Nerve Agent Auto-Injector (ATNAA). ATNAA shall be made in accordance with MPID Number 6 dated May 2, 2019.

The Solicitation will be issued under authority 10 U.S.C. 2304(c)(1).

The Government does not intend to use Part 12 for this acquisition - per FAR 10.002(d)(2).

The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract. The contract will consist of a base year and four (4) one-year options. The quantities for the base year and each option year are a minimum of 225, 000 each and a maximum of 1, 000, 000 each.

Inspection/Acceptance at Origin

FOB Destination

Delivery Destination: Susquehanna, PA

Production Lead Time is 164 days after issuance date of the delivery order (DD1155).

All responsible sources may submit a proposal and shall be considered by the Agency.

The successful contractor shall have FDA approval to sell ATNAA before award decision.

****************************************************************************

IMPORTANT NOTICES

Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form. Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on https://www.dibbs.bsm.dla.mil/. Once the solicitation is posted, it will be available for viewing on DIBBS. From the DIBBS homepage, s...
Active Contract Opportunity Notice ID SPE2DP-23-R-0002 Related Notice Department/Ind. Agency DEPT OF DEFENSE Sub-tier DEFENSE LOGISTICS AGENCY Major Command TROOP SUPPORT MEDICAL Office DLA TROOP SUPPORT
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Mar 20, 2024 07:52 am EDT
Original Response Date: Apr 04, 2024 11:59 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Apr 19, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance: Philadelphia, PA 19111 USA